Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Lawrie

Showing results (71-80 of 109) with videos related to

Pageof 11
Sort By:
British Journal of Haematology|February 13, 2001
Von Willebrand factor--cleaving protease activity in congenital thrombotic thrombocytopenic purpuraS L Allford, P Harrison, A S Lawrie, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 17, 2013
Changes in factor XIII level during pregnancyL T Sharief, A S Lawrie, I J Mackie, et al.
Digestive Diseases and Sciences|May 17, 2011
Idiopathic noncirrhotic intrahepatic portal hypertension is associated with sustained ADAMTS13 DeficiencyIan Mackie, C E Eapen, Desley Neil, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 21, 2012
Procoagulant activity in patients with sickle cell traitAndrew S Lawrie, Arnold Pizzey, Sara Trompeter, et al.
Thrombosis Research|January 24, 2012
Development and application of an automated chromogenic thrombin generation assay that is sensitive to defects in the protein C pathwayLaura Green, Omid Safa, Samuel J Machin, et al.
British Journal of Haematology|September 1, 1989
Comparison of the in vitro characteristics of von Willebrand factor in British and commercial factor VIII concentratesA S Lawrie, P Harrison, A L Armstrong, et al.
Journal of Thrombosis and Haemostasis : JTH|September 9, 2014
Anti-protein C antibodies are associated with resistance to endogenous protein C activation and a severe thrombotic phenotype in antiphospholipid syndromeD R J Arachchillage, M Efthymiou, I J Mackie, et al.
Clinical and Laboratory Haematology|June 1, 1994
Primary thrombocythaemia: a composite approach to diagnosisM Messinezy, N Westwood, B Sawyer, et al.
British Journal of Haematology|March 18, 2008
The VWF/ADAMTS13 axis in the antiphospholipid syndrome: ADAMTS13 antibodies and ADAMTS13 dysfunctionS K Austin, R D Starke, A S Lawrie, et al.
Thrombosis Research|January 4, 2015
Rivaroxaban and warfarin achieve effective anticoagulation, as assessed by inhibition of TG and in-vivo markers of coagulation activation, in patients with venous thromboembolismD R J Arachchillage, M Efthymiou, I J Mackie, et al.
Pageof 11

Showing results (71-80 of 109) with videos related to

Sort By:
Pageof 11
British Journal of Haematology|February 13, 2001
Von Willebrand factor--cleaving protease activity in congenital thrombotic thrombocytopenic purpuraS L Allford, P Harrison, A S Lawrie, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 17, 2013
Changes in factor XIII level during pregnancyL T Sharief, A S Lawrie, I J Mackie, et al.
Digestive Diseases and Sciences|May 17, 2011
Idiopathic noncirrhotic intrahepatic portal hypertension is associated with sustained ADAMTS13 DeficiencyIan Mackie, C E Eapen, Desley Neil, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 21, 2012
Procoagulant activity in patients with sickle cell traitAndrew S Lawrie, Arnold Pizzey, Sara Trompeter, et al.
Thrombosis Research|January 24, 2012
Development and application of an automated chromogenic thrombin generation assay that is sensitive to defects in the protein C pathwayLaura Green, Omid Safa, Samuel J Machin, et al.
British Journal of Haematology|September 1, 1989
Comparison of the in vitro characteristics of von Willebrand factor in British and commercial factor VIII concentratesA S Lawrie, P Harrison, A L Armstrong, et al.
Journal of Thrombosis and Haemostasis : JTH|September 9, 2014
Anti-protein C antibodies are associated with resistance to endogenous protein C activation and a severe thrombotic phenotype in antiphospholipid syndromeD R J Arachchillage, M Efthymiou, I J Mackie, et al.
Clinical and Laboratory Haematology|June 1, 1994
Primary thrombocythaemia: a composite approach to diagnosisM Messinezy, N Westwood, B Sawyer, et al.
British Journal of Haematology|March 18, 2008
The VWF/ADAMTS13 axis in the antiphospholipid syndrome: ADAMTS13 antibodies and ADAMTS13 dysfunctionS K Austin, R D Starke, A S Lawrie, et al.
Thrombosis Research|January 4, 2015
Rivaroxaban and warfarin achieve effective anticoagulation, as assessed by inhibition of TG and in-vivo markers of coagulation activation, in patients with venous thromboembolismD R J Arachchillage, M Efthymiou, I J Mackie, et al.
Pageof 11